Relationship between cannabis use, schizotypal traits, and cognitive function in healthy subjects

Psychopathology

Volumn 34, Issue 4, 2001, Pages 209-214

  Mass, Reinhard ^a   Bardong, Christina ^b   Kindl, Korana ^a   Dahme, Bernhard ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Cannabis; Cognitive functioning; Personality; Schizotypy; Substance abuse

Indexed keywords

CANNABIS;

ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; MALE; MENTAL DISEASE; NEUROPSYCHOLOGY; PERSONALITY DISORDER; QUESTIONNAIRE; RATING SCALE;

ADULT; CASE-CONTROL STUDIES; HUMANS; MALE; MARIJUANA ABUSE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 0034857198     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049309     Document Type: Article

References (46)

1. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts
2. Cannabis and schizophrenia: A longitudinal study of cases treated in Stockholm County
3. Long-term cannabis use and mental health
4. Marijuana use in schizophrenia: A clear hazard
5. Psychiatric symptoms in cannabis users
6. The search for symptoms predictive of schizophrenia
7. Putatively psychosis-prone subjects 10 years later
8. Schizotypal personality disorder in an outpatient population: Incidence and clinical characteristics
9. Hallucinogenic effects of marijuana as currently used
10. The residual neuropsychological effects of cannabis: The current status of research
11. Differential impairments of selective attention due to frequency and duration of cannabis use
12. Neuropsychological deficits in marijuana smokers
13. Span of apprehension performance, neuropsychological functioning, and indices of psychosis-proneness
14. Individual differences in negative priming: Relations with schizotypal personality traits
15. Individual differences in cognitive process: Towards an explanation of schizophrenic symptomatology
16. Prefrontal structural and functional deficits associated with individual differences in schizotypal personality
17. 'Cognitive inhibition' and positive symptomatology in schizotypy
18. Further evidence for a multidimensional personality disposition to schizophrenia in terms of cognitive inhibition
19. Frontal dysfunction and psychosis proneness in CPT-linked vulnerable adolescents
20. Relationship between childhood behavioral disturbance and later schizophrenia in the New York high-risk project
21. The Ros-common Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives
22. The New York high risk project: Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up
23. Initiation, continuation or discontinuation of cannabis use in the general population
24. The structure of schizotypy, its relation to subdiagnosis of schizophrenia and to sex and age
25. Lateralization of the 'negative priming' effects: Relationships with schizotopy and with gender
26. Body-image aberration in schizophrenia
27. Zur psychometrischen Erfassung von Schizotypie: Methodische Überprüfung und erste Validierung von zwei Skalen zur Erfassung von Risikomerkmalen
28. The SPQ: A sclale for the assessment of schizotypal personality based on DSM-III-R criteria
29. Erfassung der schizotypen Persönlichkeit nach DSM-III-R: Psychometrische Eigenschaften einer autorisierten deutschsprachigen Übersetzung des «Schizotypal Personality Questionnaire» (SPQ) von Raine
30. Psychometric high-risk paradigm, perceptual aberrations, and schizotypy: An update
31. Cognitive-perceptual, interpersonal, and disorganized features of schizotypal personality
32. Das Freiburger Persönlichkeitsinventar FPI
33. Development of a screening questionnaire for the general hospital and general practices
34. The negative priming effect: Inhibitory priming by ignored objects
35. Studies of interference in serial and verbal reactions
36. Reduced cognitive inhibition in schizotypy
37. Cannabis use correlates with schizotypy in healthy people
38. A longitudinal study of drug and alcohol use by psychosis-prone and impulsive-nonconforming individuals
39. A review of psychoactive substance use and abuse in schizophrenia: Patterns of drug choice
40. Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates
41. Alcoholism and schizophrenia: The search for perspectives. A review
42. Do patients use marijuana as an antidepressant?
43. Acute effects of drug abuse in schizophrenic patients: Clinical observations and patients' self-reports
44. Cannabis and neuroleptic agents in schizophrenia